Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

100.0%

2 terminated/withdrawn out of 2 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (2)

Showing 2 of 2 trials
NCT01079104Not ApplicableTerminated

Hepa Wash Treatment of Patients With Hepatic Dysfunction in Intensive Care Units

Role: lead

NCT01079091Not ApplicableTerminated

Hepa Wash Treatment of Patients With Acute-on-Chronic Liver Failure in Intensive Care Units

Role: lead

All 2 trials loaded